2-AMINO-3-(7-CHLORO-1H-INDOL-3-YL)PROPANOIC ACID (HCL), 97%, 100mg

IPTG, 1 g

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole, 95%, 1g

Vanadyl acetylacetonate, 95.0%, 500g

4-(4-nitro-phenyl)-3-oxo-butyric acid ethyl ester, 97%, 100mg

Tris(acetonitrile)cyclopentadienylruthenium(II) hexafluorophosphate, 98.0%, 10g

3-Fluoro-N-(piperidin-4-yl)benzenesulfonamide hydrochloride, 95.0%, 1g

Ethyl 3-amino-3-(4-chlorophenyl)propanoate hydrochloride, 97%, 1g

[1,1'-Biphenyl]-4-yl(phenyl)methanol, 95+%, 1g

Oprozomib, 99.71%, 10mg

[2-(7H-pyrrolo[2,3-b]pyridin-7-yl)ethyl]amine dihydrochloride, 95.0%, 250mg

4-(TRIFLUOROMETHYL)-1H-INDAZOLE, 95%, 250mg

1-(3-Methoxyphenyl)-2,3-butadien-1-one, 1g